Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SANUWAVE Health (SNWV) Change in Accured Expenses (2023 - 2025)

SANUWAVE Health (SNWV) has disclosed Change in Accured Expenses for 9 consecutive years, with -$294000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Change in Accured Expenses fell 133.03% to -$294000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was -$3.8 million, a 2258.99% decrease, with the full-year FY2024 number at -$800000.0, up 61.78% from a year prior.
  • Change in Accured Expenses was -$294000.0 for Q3 2025 at SANUWAVE Health, down from $774000.0 in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $955000.0 in Q1 2024 to a low of -$3.5 million in Q4 2024.
  • A 3-year average of -$453727.3 and a median of -$294000.0 in 2025 define the central range for Change in Accured Expenses.
  • Biggest YoY gain for Change in Accured Expenses was 7990.91% in 2024; the steepest drop was 362.71% in 2024.
  • SANUWAVE Health's Change in Accured Expenses stood at -$767000.0 in 2023, then crashed by 362.71% to -$3.5 million in 2024, then skyrocketed by 91.72% to -$294000.0 in 2025.
  • Per Business Quant, the three most recent readings for SNWV's Change in Accured Expenses are -$294000.0 (Q3 2025), $774000.0 (Q2 2025), and -$774000.0 (Q1 2025).